Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging
Status: | Recruiting |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 35 - Any |
Updated: | 10/5/2018 |
Start Date: | September 10, 2018 |
End Date: | June 2019 |
Contact: | Avice O'Connell, MD |
Email: | avice_oconnell@urmc.rochester.edu |
Phone: | 585-487-3308 |
Up to one hundred (100) female patients will be enrolled and consented to participate in the
study. These women will be enrolled from screening assigned BIRADS 0, patient complaint, or
referral for second opinion. The enrolled patient will accept CE-CBBCT scans within 4 weeks
of her diagnostic mammography and before breast biopsy if biopsy is needed. The final
diagnostic workup outcome of these enrolled patients needs to include at least 30 confirmed
cancers cases.
study. These women will be enrolled from screening assigned BIRADS 0, patient complaint, or
referral for second opinion. The enrolled patient will accept CE-CBBCT scans within 4 weeks
of her diagnostic mammography and before breast biopsy if biopsy is needed. The final
diagnostic workup outcome of these enrolled patients needs to include at least 30 confirmed
cancers cases.
Inclusion Criteria:
Female sex Age 35 years or older Any ethnicity Have an abnormality detected by Breast Self
Exam (BSE), or Clinical Breast Exam (CBE), or have an abnormality detected by an imaging
modality.
Will undergo study imaging within four weeks from the date of diagnostic mammography, prior
to breast biopsy (if needed).
Able to provide informed consent Post-menopausal, surgically sterile, or effective birth
control. For women of childbearing potential, negative pregnancy test or has signed
pregnancy test waiver If required by standard of care, eGFR >45 within 48 hours to 6 weeks
of CE-CBBCT exam
Exclusion Criteria:
Pregnancy Lactation Unknown pregnancy status AND has refused pregnancy testing and has
refused to sign a pregnancy test waiver Women who are unable or unwilling to understand or
to provide informed consent Women with physical limitations that may prohibit resting prone
on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace
maker.
Women who are unable to tolerate study constraints.
Women who have received radiation treatments to the thorax or breast area for malignant and
nonmalignant conditions, such as (but not limited to):
Treatment for enlarged thymus gland as an infant Irradiation for benign breast conditions,
including breast inflammation after giving birth Treatment for Hodgkin's disease Women who
have participated in a prior breast clinical trial that gave additional radiation dose,
such as an additional mammogram.
Women who have received large numbers of diagnostic x-ray examinations for monitoring of
disease such as (but not limited to):
Tuberculosis Severe scoliosis
Additional Exclusion Criteria Due To Contrast Injection:
Allergic to iodinated contrast material Previous non-ionic contrast reaction Any conditions
below regardless of eGFR Renal Disease Chronic renal dysfunction Renal Transplant (or
waiting for a transplant) One kidney or other birth defect Polycystic Kidneys Renal
Tumor/Renal Cancer History of liver failure/cirrhosis/liver transplant/pending liver
transplant Congestive heart failure Multiple myeloma Hyperthyroidism Pheochromocytoma
Sickle Cell Disease Asthma requiring daily use of inhaler
Additional exclusion criteria due to machine limitations Patient's body weight is over the
limit of the scanner table (440 lbs or 200kg)
We found this trial at
1
site
1000 South Avenue
Rochester, New York 14623
Rochester, New York 14623
Principal Investigator: Avice O'Connell, MD
Phone: 585-487-3308
Click here to add this to my saved trials